Hannover Medical School
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mh-hannover.de
Clinical Trials
232
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (144 trials with phase data)• Click on a phase to view related trials
Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
- Conditions
- Self-EfficacyHealth LiteracyLiver CirrhosisALD - Alcoholic Liver Disease
- First Posted Date
- 2025-09-11
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 200
- Registration Number
- NCT07169526
- Locations
- 🇩🇪
Medizinische Hochschule Hannover, Hanover, Germany
T-cell Therapy in Patients With PML
- Conditions
- Progressive Multifocal Leucoencephalopathy (PML)
- Interventions
- Drug: Application of T-lymphocytes
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 23
- Registration Number
- NCT06990087
Data Analysis and Evaluation of the Incidence of Life-threatening Ventricular Arrhythmias in Patients with Newly Diagnosed Cardiomyopathies of NICM or MI/CAD Origin PROTECTED from SCD by a WCD
- Conditions
- Cardiomyopathy (Ischemic or Non-Ischemic)
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 19598
- Registration Number
- NCT06883383
- Locations
- 🇩🇪
Hannover Medical School, Hannover, Germany
Observational Study on the Clinical Use of Ex Vivo Lung Perfusion (XPS™) for Lung Transplantation
- Conditions
- Lung Transplantation
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 20
- Registration Number
- NCT06795516
- Locations
- 🇩🇪
Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover, Germany
Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia
- Conditions
- Schizophrenia Patients
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 60
- Registration Number
- NCT06740747
- Locations
- 🇩🇪
Hannover Medical School, Hannover, Niedersachsen, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 39
- Next
News
Cannabis-Based Drug Shows Significant Pain Relief in Large Clinical Trial for Chronic Lower Back Pain
Vertanical's experimental cannabis medication demonstrated statistically significant pain reduction in an 800-patient study, with participants reporting nearly 2-point improvement on an 11-point pain scale compared to 1.4 points for placebo.
Digitoxin Reduces Death and Hospitalization Risk in Advanced Heart Failure Patients
The DIGIT-HF trial demonstrated that digitoxin significantly reduced the composite risk of all-cause death or hospitalization for worsening heart failure by 18% compared to placebo in patients with heart failure with reduced ejection fraction.
Viromed's Cold Plasma Technology Demonstrates Potential to Prevent 6,000 Deaths Annually from Ventilator-Associated Pneumonia
Preclinical study by Hannover Medical School shows Viromed's cold plasma technology could prevent up to 6,000 deaths per year in Germany from ventilator-associated pneumonia.
Viromed Medical AG Advances Cold Plasma Technology as "Digital Antibiotic" for Ventilator-Associated Pneumonia Prevention
Viromed Medical AG is advancing research on cold plasma technology as a potential "digital antibiotic" for preventing ventilator-associated pneumonia (VAP), which affects 23-36% of mechanically ventilated patients in Germany with a mortality rate of 10-13%.